Encompass Health vs Glaukos

Encompass Health (EHC), health care, and Glaukos (GKOS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Glaukos is worth $14.4B on the stock market and Encompass Health $13.5B: Glaukos is valued at 6% more. Over the past year Encompass Health's share price has moved +26.1% and Glaukos's +167%.

Key facts

Encompass Health market value
$13.5B
Glaukos market value
$14.4B
Encompass Health P/E
22.1
Encompass Health revenue
$5.9BFY to 2025-12-31
Glaukos revenue
$507.4MFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Encompass Health vs Glaukos: every measure side by side
Measure Encompass Health Glaukos
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$13.5Blower$14.4Bhigher
Revenue$5.9Bhigher$507.4Mlower
Earnings$566.2Mhigher-$187.7Mlower
Employees29,875higher1,094lower
Total assets$7.1Bhigher$893.5Mlower
Valuation
P/E22.1—
P/S2.3lower28.4higher
P/B5.1lower20.1higher
Dividend yield0.55%higher0.00%lower
Profitability
Operating margin—-39.3%
Balance sheet
Net assets$2.4Bhigher$656.2Mlower
Total liabilities$3.8Bhigher$237.3Mlower
Total debt$2.5B—
Cash on hand$72.2Mlower$90.8Mhigher
Price change
Today-2.98%lower-0.67%higher
1 year+26.1%lower+167%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Encompass Health only (3)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Encompass Health / Glaukos). Who owns EHC · Who owns GKOS

Further comparisons

Learn

Questions and answers

Which is bigger, Encompass Health or Glaukos?

By market value, Glaukos is the larger: $14.4B against $13.5B for Encompass Health. By revenue in its latest fiscal year, Encompass Health is the larger: $5.9B against $507.4M for Glaukos.

Which has the higher dividend yield?

Encompass Health: 0.55%, against 0.00% for Glaukos. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Encompass Health and Glaukos?

In their latest 13F filings, Brandon Haley holds both.

Cite this page

Funkfolio, “Encompass Health vs Glaukos”, data as of 18 November 2026. https://funkfolio.com/compare/ehc-vs-gkos

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.